XML 80 R62.htm IDEA: XBRL DOCUMENT
v3.22.0.1

Identifiable Intangible Assets - Additional Information (Detail) $ in Millions | 12 Months Ended
--- | ---
Dec. 31, 2021 USD ($) | Dec. 31, 2020 USD ($) | Dec. 31, 2019 USD ($)
Finite-Lived Intangible Assets [Line Items] |  |  |
Amortization of intangible assets useful life | 10 years |  |
Amortization of intangible assets | $ 802 | $ 1,020 | $ 1,113
2022 | 689 |  |
2023 | 711 |  |
2024 | 651 |  |
2025 | 630 |  |
2026 | 652 |  |
Impairment of intangible assets excluding goodwill | 424 | 1,502 | 1,639
In Process Research And Development To Product Rights [Member] |  |  |
Finite-Lived Intangible Assets [Line Items] |  |  |
Prior periods adjustments | 192 |  |
lenalidomide [Member] |  |  |
Finite-Lived Intangible Assets [Line Items] |  |  |
Prior periods adjustments | $ 153 |  |
Minimum [Member] | Measurement input, discount rate [Member] |  |  |
Finite-Lived Intangible Assets [Line Items] |  |  |
Business combination, contingent consideration, liability, measurement input | 7.5 |  |
Maximum [Member] | Measurement input, discount rate [Member] |  |  |
Finite-Lived Intangible Assets [Line Items] |  |  |
Business combination, contingent consideration, liability, measurement input | 8.0 |  |
Lenalidomide Product [Member] |  |  |
Finite-Lived Intangible Assets [Line Items] |  |  |
Impairment of intangible assets excluding goodwill |  | 262 | 125
In Process Research and Development [Member] |  |  |
Finite-Lived Intangible Assets [Line Items] |  |  |
Impairment of intangible assets excluding goodwill |  | 797 | 681
In Process Research and Development [Member] | Minimum [Member] |  |  |
Finite-Lived Intangible Assets [Line Items] |  |  |
Business combination, contingent consideration, liability, measurement input | 0.0725 |  |
In Process Research and Development [Member] | Minimum [Member] | Measurement input, discount rate [Member] |  |  |
Finite-Lived Intangible Assets [Line Items] |  |  |
Business combination, contingent consideration, liability, measurement input | 0.20 |  |
In Process Research and Development [Member] | Maximum [Member] |  |  |
Finite-Lived Intangible Assets [Line Items] |  |  |
Business combination, contingent consideration, liability, measurement input | 0.10 |  |
In Process Research and Development [Member] | Maximum [Member] | Measurement input, discount rate [Member] |  |  |
Finite-Lived Intangible Assets [Line Items] |  |  |
Business combination, contingent consideration, liability, measurement input | 0.90 |  |
In Process Research and Development [Member] | Generic Pipeline Products [Member] |  |  |
Finite-Lived Intangible Assets [Line Items] |  |  |
Impairment of intangible assets excluding goodwill | $ 127 |  |
Identifiable product rights [Member] |  |  |
Finite-Lived Intangible Assets [Line Items] |  |  |
Impairment of intangible assets excluding goodwill |  | 705 | 958
Identifiable product rights [Member] | Lenalidomide Product [Member] |  |  |
Finite-Lived Intangible Assets [Line Items] |  |  |
Impairment of intangible assets excluding goodwill | 267 |  |
Actavis [Member] | In Process Research and Development [Member] |  |  |
Finite-Lived Intangible Assets [Line Items] |  |  |
Impairment of intangible assets excluding goodwill |  | 110 | 59
Actavis [Member] | In Process Research and Development [Member] | Lenalidomide Product [Member] |  |  |
Finite-Lived Intangible Assets [Line Items] |  |  |
Impairment of intangible assets excluding goodwill |  | 300 | 497
Actavis [Member] | Identifiable product rights [Member] |  |  |
Finite-Lived Intangible Assets [Line Items] |  |  |
Impairment of intangible assets excluding goodwill | 297 | 398 | 647
AUSTEDO [Member] | In Process Research and Development [Member] |  |  |
Finite-Lived Intangible Assets [Line Items] |  |  |
Impairment of intangible assets excluding goodwill |  | 211 |
International Markets [Member] | Discontinued business [Member] |  |  |
Finite-Lived Intangible Assets [Line Items] |  |  |
Impairment of intangible assets excluding goodwill |  |  | 123
Japan [Member] | Identifiable product rights [Member] |  |  |
Finite-Lived Intangible Assets [Line Items] |  |  |
Impairment of intangible assets excluding goodwill |  | $ 165 | $ 128
United States [Member] | Actavis [Member] | Identifiable product rights [Member] |  |  |
Finite-Lived Intangible Assets [Line Items] |  |  |
Impairment of intangible assets excluding goodwill | $ 30 |  |

X
- Definition The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 2 -Subparagraph (a)(2) -URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 45 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274 + Details
Name: | us-gaap_AmortizationOfIntangibleAssets
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Value of input used to measure contingent consideration liability from business combination. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (bbb)(2) -URI http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258 + Details
Name: | us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput
Namespace Prefix: | us-gaap_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | instant

X
- Definition Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. + References No definition available. + Details
Name: | us-gaap_FiniteLivedIntangibleAssetUsefulLife
Namespace Prefix: | us-gaap_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 2 -Subparagraph (a)(3) -URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275 + Details
Name: | us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 2 -Subparagraph (a)(3) -URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275 + Details
Name: | us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 2 -Subparagraph (a)(3) -URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275 + Details
Name: | us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 2 -Subparagraph (a)(3) -URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275 + Details
Name: | us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 2 -Subparagraph (a)(3) -URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275 + Details
Name: | us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_FiniteLivedIntangibleAssetsLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 3 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275 + Details
Name: | us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The amount of a reclassification adjustment made to prior period financial statement amounts. + References No definition available. + Details
Name: | us-gaap_PriorPeriodReclassificationAdjustment
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | us-gaap_ReclassificationTypeAxis=teva_InprocessresearchandDevelopmenttoProductRightsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ReclassificationTypeAxis=teva_LenalidomideMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MinimumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=teva_LenalidomideProductMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=teva_GenericPipelineProductsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=teva_ProductRightsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=teva_ActavisMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=teva_AustedoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=teva_InternationalMarketsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | teva_DiscontinuationOfBusinessAxis=teva_DiscontinuedBusinessMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=country_JP
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=country_US
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |